{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T17:39:35Z","timestamp":1778607575125,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005423","name":"Akademiska Sjukhuset","doi-asserted-by":"publisher","award":["ALF 937815"],"award-info":[{"award-number":["ALF 937815"]}],"id":[{"id":"10.13039\/501100005423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>It has been repeatedly shown that men infected by SARS-CoV-2 face a twofold higher likelihood of dying, being hospitalized or admitted to the intensive care unit compared to women, despite taking into account relevant confounders. It has been hypothesized that these discrepancies are related to sex steroid hormone differences with estrogens being negatively correlated with disease severity. The objective of this study was therefore to evaluate COVID-19-related mortality and morbidity among peri- and postmenopausal women in relation to estrogen-containing menopause hormonal treatments (MHT).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a national register-based matched cohort study performed in Sweden between January 1 to December 31, 2020. Study participants comprised women over the age of 53\u00a0years residing in Sweden. Exposure was defined as prescriptions of local estrogens, systemic estrogens with and without progestogens, progestogens alone, or tibolone. MHT users were then compared with a matched cohort of non-users. The primary outcome consisted of COVID-19 mortality, whereas the secondary outcomes included inpatient hospitalizations\/outpatient visits and confirmed SARS-CoV-2 infection. Multivariable adjusted Cox regression-derived hazard ratios (HRs) were calculated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Use of systemic estrogens alone is associated with increased COVID-19 mortality among older women (aHR 4.73, 1.22 to 18.32), but the association is no longer significant when discontinuation of estrogen use is accounted for. An increased risk for COVID-19 infection is further observed for women using combined systemic estrogens and progestogens (aHR 1.06, 1.00 to 1.13) or tibolone (aHR 1.21, 1.01 to 1.45). Use of local estrogens is associated with an increased risk for COVID-19-related death (aHR 2.02,1.45 to 2.81) as well as for all secondary outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Systemic or local use of estrogens does not decrease COVID-19 morbidity and mortality to premenopausal background levels. Excess risk for COVID-19 morbidity and mortality was noted among older women and those discontinuing systemic estrogens. Higher risk for death was also noted among women using local estrogens, for which non-causal mechanisms such as confounding by comorbidity or frailty seem to be the most plausible underlying explanations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration details<\/jats:title>\n                <jats:p>Not applicable.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-024-03297-z","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T12:03:01Z","timestamp":1709035381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Estrogen-modulating treatment among mid-life women and COVID-19 morbidity and mortality: a multiregister nationwide matched cohort study in Sweden"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2253-4682","authenticated-orcid":false,"given":"Evangelia","family":"Elenis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena Kopp","family":"Kallner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Karalexi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"H\u00e4gg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Linder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Fall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotios C.","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alkistis","family":"Skalkidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"issue":"3","key":"3297_CR1","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.ajog.2020.05.039","volume":"223","author":"A Cagnacci","year":"2020","unstructured":"Cagnacci A, Xholli A. Age-related difference in the rate of coronavirus disease 2019 mortality in women versus men. Am J Obstet Gynecol. 2020;223(3):453\u20134.","journal-title":"Am J Obstet Gynecol"},{"issue":"7821","key":"3297_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584(7821):430\u20136.","journal-title":"Nature"},{"issue":"6","key":"3297_CR3","doi-asserted-by":"publisher","first-page":"e0270192","DOI":"10.1371\/journal.pone.0270192","volume":"17","author":"T Meister","year":"2022","unstructured":"Meister T, Pisarev H, Kolde R, Kalda R, Suija K, Milani L, et al. Clinical characteristics and risk factors for COVID-19 infection and disease severity: a nationwide observational study in Estonia. PLoS ONE. 2022;17(6):e0270192.","journal-title":"PLoS ONE"},{"issue":"1","key":"3297_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12916-020-01851-z","volume":"18","author":"U Seeland","year":"2020","unstructured":"Seeland U, Coluzzi F, Simmaco M, Mura C, Bourne PE, Heiland M, et al. Evidence for treatment with estradiol for women with SARS-CoV-2 infection. BMC Med. 2020;18(1):369.","journal-title":"BMC Med"},{"issue":"7","key":"3297_CR5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41577-020-0348-8","volume":"20","author":"EP Scully","year":"2020","unstructured":"Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20(7):442\u20137.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"3297_CR6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/aje\/kwh056","volume":"159","author":"J Karlberg","year":"2004","unstructured":"Karlberg J, Chong DS, Lai WY. Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? Am J Epidemiol. 2004;159(3):229\u201331.","journal-title":"Am J Epidemiol"},{"issue":"Suppl 1","key":"3297_CR7","first-page":"9","volume":"8 Suppl","author":"M Chan-Yeung","year":"2003","unstructured":"Chan-Yeung M, Xu RH. SARS: epidemiology. Respirology. 2003;8 Suppl(Suppl 1):9\u201314.","journal-title":"Respirology"},{"key":"3297_CR8","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2147\/IJGM.S67061","volume":"7","author":"IG Alghamdi","year":"2014","unstructured":"Alghamdi IG, Hussain II, Almalki SS, Alghamdi MS, Alghamdi MM, El-Sheemy MA. The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health. Int J Gen Med. 2014;7:417\u201323.","journal-title":"Int J Gen Med"},{"key":"3297_CR9","doi-asserted-by":"publisher","first-page":"928171","DOI":"10.3389\/fimmu.2022.928171","volume":"13","author":"M Averyanova","year":"2022","unstructured":"Averyanova M, Vishnyakova P, Yureneva S, Yakushevskaya O, Fatkhudinov T, Elchaninov A, et al. Sex hormones and immune system: menopausal hormone therapy in the context of COVID-19 pandemic. Front Immunol. 2022;13:928171.","journal-title":"Front Immunol"},{"issue":"1","key":"3297_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6118\/jmm.21036","volume":"28","author":"SW Choi","year":"2022","unstructured":"Choi SW, Kim J, Lee JH, Kim SK, Lee SR, Kim SH, et al. Hormone therapy in the era of the COVID-19 pandemic: a review. J Menopausal Med. 2022;28(1):1\u20138.","journal-title":"J Menopausal Med"},{"key":"3297_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s41232-020-00146-3","volume":"40","author":"S Hojyo","year":"2020","unstructured":"Hojyo S, Uchida M, Tanaka K, Hasebe R, Tanaka Y, Murakami M, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen. 2020;40:37.","journal-title":"Inflamm Regen"},{"issue":"2","key":"3297_CR12","doi-asserted-by":"publisher","first-page":"e053032","DOI":"10.1136\/bmjopen-2021-053032","volume":"12","author":"M Sund","year":"2022","unstructured":"Sund M, Fonseca-Rodriguez O, Josefsson A, Welen K, Fors Connolly AM. Association between pharmaceutical modulation of oestrogen in postmenopausal women in Sweden and death due to COVID-19: a cohort study. BMJ Open. 2022;12(2):e053032.","journal-title":"BMJ Open"},{"issue":"9","key":"3297_CR13","doi-asserted-by":"publisher","first-page":"e0257051","DOI":"10.1371\/journal.pone.0257051","volume":"16","author":"R Costeira","year":"2021","unstructured":"Costeira R, Lee KA, Murray B, Christiansen C, Castillo-Fernandez J, Ni Lochlainn M, et al. Estrogen and COVID-19 symptoms: associations in women from the COVID Symptom Study. PLoS ONE. 2021;16(9):e0257051.","journal-title":"PLoS ONE"},{"issue":"6","key":"3297_CR14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1093\/fampra\/cmac041","volume":"39","author":"H Dambha-Miller","year":"2022","unstructured":"Dambha-Miller H, Hinton W, Wilcox CR, Joy M, Feher M, de Lusignan S. Mortality in COVID-19 among women on hormone replacement therapy: a retrospective cohort study. Fam Pract. 2022;39(6):1049\u201355.","journal-title":"Fam Pract"},{"key":"3297_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.maturitas.2022.07.006","volume":"165","author":"MS Vallejo","year":"2022","unstructured":"Vallejo MS, Blumel JE, Bencosme A, Calle A, Dextre M, Diaz K, et al. Factors affecting climacteric women with SARS-CoV-2 infection: a multinational Latin America study (REDLINC XI). Maturitas. 2022;165:33\u20137.","journal-title":"Maturitas"},{"issue":"45","key":"3297_CR16","first-page":"3014","volume":"106","author":"JF Ludvigsson","year":"2009","unstructured":"Ludvigsson JF, Myrelid P. Swibreg\u2013a new version of national IBD registry. Lakartidningen. 2009;106(45):3014\u20135.","journal-title":"Lakartidningen"},{"key":"3297_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"issue":"9","key":"3297_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","volume":"32","author":"HL Brooke","year":"2017","unstructured":"Brooke HL, Talback M, Hornblad J, Johansson LA, Ludvigsson JF, Druid H, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765\u201373.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"3297_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson JF, Almqvist C, Bonamy AK, Ljung R, Michaelsson K, Neovius M, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31(2):125\u201336.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"3297_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","volume":"34","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson JF, Svedberg P, Olen O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423\u201337.","journal-title":"Eur J Epidemiol"},{"key":"3297_CR21","unstructured":"Agency TPH. SMINET [Available from: https:\/\/www.folkhalsomyndigheten.se\/sminet\/om-sminet\/."},{"key":"3297_CR22","doi-asserted-by":"crossref","unstructured":"Sundell M, Brynhildsen J, Fredrikson M, Hoffmann M, Spetz Holm AC. Insufficient use of menopausal hormone therapy in Swedish women with early or premature menopause caused by bilateral oophorectomy: a register-based study. BJOG. 2023.","DOI":"10.1111\/1471-0528.17647"},{"issue":"8","key":"3297_CR23","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.mayocp.2020.05.013","volume":"95","author":"RA Al-Lami","year":"2020","unstructured":"Al-Lami RA, Urban RJ, Volpi E, Algburi AMA, Baillargeon J. Sex hormones and novel corona virus infectious disease (COVID-19). Mayo Clin Proc. 2020;95(8):1710\u20134.","journal-title":"Mayo Clin Proc"},{"issue":"48","key":"3297_CR24","doi-asserted-by":"publisher","first-page":"eadd4150","DOI":"10.1126\/sciadv.add4150","volume":"8","author":"O Solis","year":"2022","unstructured":"Solis O, Beccari AR, Iaconis D, Talarico C, Ruiz-Bedoya CA, Nwachukwu JC, et al. The SARS-CoV-2 spike protein binds and modulates estrogen receptors. Sci Adv. 2022;8(48):eadd4150.","journal-title":"Sci Adv"},{"key":"3297_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.maturitas.2020.04.019","volume":"137","author":"I Ramirez","year":"2020","unstructured":"Ramirez I, De la Viuda E, Baquedano L, Coronado P, Llaneza P, Mendoza N, et al. Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: recommendations from the Spanish Menopause Society, Sociedad Espanola de Ginecologia y Obstetricia and Sociedad Espanola de Trombosis y Hemostasia. Maturitas. 2020;137:57\u201362.","journal-title":"Maturitas"},{"issue":"3","key":"3297_CR26","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/GME.0000000000001463","volume":"27","author":"RJ Santen","year":"2020","unstructured":"Santen RJ, Mirkin S, Bernick B, Constantine GD. Systemic estradiol levels with low-dose vaginal estrogens. Menopause. 2020;27(3):361\u201370.","journal-title":"Menopause"},{"issue":"4","key":"3297_CR27","first-page":"e7586","volume":"12","author":"K Angelou","year":"2020","unstructured":"Angelou K, Grigoriadis T, Diakosavvas M, Zacharakis D, Athanasiou S. The genitourinary syndrome of menopause: an overview of the recent data. Cureus. 2020;12(4):e7586.","journal-title":"Cureus"},{"issue":"10","key":"3297_CR28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/GME.0000000000001130","volume":"25","author":"LE Waetjen","year":"2018","unstructured":"Waetjen LE, Crawford SL, Chang PY, Reed BD, Hess R, Avis NE, et al. Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study. Menopause. 2018;25(10):1094\u2013104.","journal-title":"Menopause"},{"issue":"3","key":"3297_CR29","doi-asserted-by":"publisher","first-page":"e017416","DOI":"10.1161\/JAHA.120.017416","volume":"10","author":"RC Thurston","year":"2021","unstructured":"Thurston RC, Aslanidou Vlachos HE, Derby CA, Jackson EA, Brooks MM, Matthews KA, et al. Menopausal vasomotor symptoms and risk of incident cardiovascular disease events in SWAN. J Am Heart Assoc. 2021;10(3):e017416.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"3297_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1080\/13697137.2021.2006176","volume":"25","author":"A Cagnacci","year":"2022","unstructured":"Cagnacci A, Gambera A, Bonaccorsi G, Xholli A, study A. Relation between blood pressure and genito-urinary symptoms in the years across the menopausal age. Climacteric. 2022;25(4):395\u2013400.","journal-title":"Climacteric"},{"key":"3297_CR31","doi-asserted-by":"crossref","unstructured":"Peters KJ. What is genitourinary syndrome of menopause and why should we care? Perm J. 2021;25.","DOI":"10.7812\/TPP\/20.248"},{"key":"3297_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.maturitas.2017.02.004","volume":"99","author":"M Caretto","year":"2017","unstructured":"Caretto M, Giannini A, Russo E, Simoncini T. Preventing urinary tract infections after menopause without antibiotics. Maturitas. 2017;99:43\u20136.","journal-title":"Maturitas"},{"key":"3297_CR33","doi-asserted-by":"crossref","unstructured":"Ciesielska A, Kusiak A, Ossowska A, Grzybowska ME. Changes in the oral cavity in menopausal women-a narrative review. Int J Environ Res Public Health. 2021;19(1).","DOI":"10.3390\/ijerph19010253"},{"issue":"4","key":"3297_CR34","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.maturitas.2010.08.003","volume":"67","author":"CM Gameiro","year":"2010","unstructured":"Gameiro CM, Romao F, Castelo-Branco C. Menopause and aging: changes in the immune system\u2013a review. Maturitas. 2010;67(4):316\u201320.","journal-title":"Maturitas"},{"key":"3297_CR35","unstructured":"Pressrum COVID-19. [cited 2022\u201311\u201308]. Available from: https:\/\/www.socialstyrelsen.se\/om-socialstyrelsen\/pressrum\/press\/ny-statistik-om-smittade-och-avlidna-i-covid-19-70-ar-och-aldre\/."},{"issue":"12","key":"3297_CR36","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/apa.15582","volume":"109","author":"JF Ludvigsson","year":"2020","unstructured":"Ludvigsson JF. The first eight months of Sweden\u2019s COVID-19 strategy and the key actions and actors that were involved. Acta Paediatr. 2020;109(12):2459\u201371.","journal-title":"Acta Paediatr"},{"issue":"1","key":"3297_CR37","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1038\/s41467-020-18926-3","volume":"11","author":"S Drefahl","year":"2020","unstructured":"Drefahl S, Wallace M, Mussino E, Aradhya S, Kolk M, Branden M, et al. A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden. Nat Commun. 2020;11(1):5097.","journal-title":"Nat Commun"},{"key":"3297_CR38","doi-asserted-by":"publisher","first-page":"673451","DOI":"10.3389\/fpubh.2021.673451","volume":"9","author":"M Yoshikawa","year":"2021","unstructured":"Yoshikawa M, Asaba K. Educational attainment decreases the risk of COVID-19 severity in the European population: a two-sample Mendelian randomization study. Front Public Health. 2021;9:673451.","journal-title":"Front Public Health"},{"issue":"1","key":"3297_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12916-020-01640-8","volume":"18","author":"CL Niedzwiedz","year":"2020","unstructured":"Niedzwiedz CL, O\u2019Donnell CA, Jani BD, Demou E, Ho FK, Celis-Morales C, et al. Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank. BMC Med. 2020;18(1):160.","journal-title":"BMC Med"},{"issue":"1","key":"3297_CR40","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1186\/s12889-022-13618-7","volume":"22","author":"IW Tang","year":"2022","unstructured":"Tang IW, Vieira VM, Shearer E. Effect of socioeconomic factors during the early COVID-19 pandemic: a spatial analysis. BMC Public Health. 2022;22(1):1212.","journal-title":"BMC Public Health"},{"issue":"1","key":"3297_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13293-021-00363-6","volume":"12","author":"XW Wang","year":"2021","unstructured":"Wang XW, Hu H, Xu ZY, Zhang GK, Yu QH, Yang HL, et al. Association of menopausal status with COVID-19 outcomes: a propensity score matching analysis. Biol Sex Differ. 2021;12(1):16.","journal-title":"Biol Sex Differ"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03297-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-024-03297-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-024-03297-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T12:05:29Z","timestamp":1709035529000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-024-03297-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3297"],"URL":"https:\/\/doi.org\/10.1186\/s12916-024-03297-z","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"8 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Swedish Ethical Review Authority (Dnr 2020\/03936 with date of approval 17\/08\/2020). The need for written or oral informed consent was waived since all data received from the Swedish registries were pseudonymized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed the ICMJE uniform disclosure form at  on request from the corresponding author) and declare the following: no support from any organization for the submitted work; EE has received lecture fee from Gedeon Richter and research grant from Ferring Pharmaceuticals and serves as the medical advisor of Tilly AB; AS has received a one-time consultant fee from Biogen Inc., none of which are in any way related to this manuscript. HKK receives honorariums for lectures on contraception, fibroid care, and endometriosis from Abbvie, Actavis, Bayer, Gedeon Richter Exeltis, Nordic Pharma, Natural Cycles, Mithra, Teva, Merck, Organon, Ferring, and Consilient Health and provides expert opinions for Bayer, Evolan, Gedeon Richter, Exeltis, Merck, Teva, TV4 och Natural Cycles, Pharmiva, Dynamic Code (past), Ellen, Estercare, Pharmiva, Gedea, Gesynta, Leia, and Essity. HKK is an investigator in trials sponsored by Bayer, MSD, Mithra, Ethicon, Azanta, Gedeon Richter, Gedea, and Pharmiva. HKK teaches in courses sponsored by Organon, Bayer, and Gedeon Richter. ML and DH report participation in research projects funded by pharmaceutical companies, all regulator-mandated phase IV-studies, all with funds paid to the institution where they were employed (no personal fees) and with no relation to the work reported in this paper. The other authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}